Arrowhead Pharmaceuticals, Inc. EPS (Earnings per Share) 2003–2025
Arrowhead Pharmaceuticals, Inc. reported $-0.01 of earnings per share for fiscal 2025. That was 99.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +98.8%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-0.01 | +99.8% |
| FY 2024 | $-5.00 | -160.4% |
| FY 2023 | $-1.92 | -15.0% |
| FY 2022 | $-1.67 | -22.8% |
| FY 2021 | $-1.36 | -61.9% |
| FY 2020 | $-0.84 | -221.7% |
| FY 2019 | $0.69 | +206.2% |
| FY 2018 | $-0.65 | -38.3% |
| FY 2017 | $-0.47 | — |
| FY 2016 | $0.00 | — |
| FY 2015 | $0.00 | — |
| FY 2014 | $0.00 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | +100.0% |
| FY 2011 | $-0.40 | +55.6% |
| FY 2010 | $-0.90 | — |
| FY 2009 | $0.00 | — |
| FY 2008 | $0.00 | — |
| FY 2007 | $0.00 | — |
| FY 2006 | $0.00 | — |
| FY 2005 | $0.00 | — |
| FY 2004 | $0.00 | — |
| FY 2003 | $0.00 | — |
Source: Arrowhead Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ARWR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Arrowhead Pharmaceuticals, Inc. reported $-0.01 of earnings per share for fiscal 2025. That was 99.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +98.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Arrowhead Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArrowhead Pharmaceuticals, Inc. — frequently asked questions
What is Arrowhead Pharmaceuticals, Inc.'s earnings per share?
Arrowhead Pharmaceuticals, Inc. (ARWR) reported earnings per share of $-0.01 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arrowhead Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.